Correction To: An Adapted European Leukemianet Genetic Risk Stratification for Acute Myeloid Leukemia Patients Undergoing Allogeneic Hematopoietic Cell Transplant. a CIBMTR Analysis

Authors

Antonio M. Jimenez Jimenez, Division of Transplantation and Cellular Therapy, University of Miami Miller School of Medicine, Miami, FL, USA. amjimenez@med.miami.edu.
Marcos De Lima, Department of Medicine, Seidman Cancer Center, University Hospitals Case Medical Center, Cleveland, OH, USA.
Krishna V. Komanduri, Division of Transplantation and Cellular Therapy, University of Miami Miller School of Medicine, Miami, FL, USA.
Trent P. Wang, Division of Transplantation and Cellular Therapy, University of Miami Miller School of Medicine, Miami, FL, USA.
Mei-Jie Zhang, (CIBMTR)® Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.
Karen Chen, (CIBMTR)® Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.
Hisham Abdel-Azim, Division of Hematology, Oncology and Blood & Marrow Transplantation, Children's Hospital Los Angeles, University of Southern California Keck School of Medicine, Los Angeles, CA, USA.Follow
Muhammad Bilal Abid, Divisions of Hematology/Oncology & Infectious Diseases, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.
Mahmoud Aljurf, Department of Oncology, King Faisal Specialist Hospital Center & Research, Riyadh, Saudi Arabia.Follow
Hassan Alkhateeb, Mayo Clinic Rochester, Rochester, MN, USA.
Amer Assal, Columbia University Irving Medical Center, Department of Medicine, Bone Marrow Transplant and Cell Therapy Program, New York, NY, USA.Follow
Ulrike Bacher, Department of Hematology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
Frédéric Baron, CHU and University of Liege, Liege, Belgium.
Minoo Battiwalla, Sarah Cannon Blood Cancer Network, Nashville, TN, USA.
Amer Beitinjaneh, Division of Transplantation and Cellular Therapy, University of Miami Miller School of Medicine, Miami, FL, USA.
Nelli Bejanyan, Department of Blood & Marrow Transplant and Cellular Immunotherapy (BMT CI), Moffitt Cancer Center, Tampa, FL, USA.
Vijaya Raj Bhatt, The Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE, USA.
Michael Byrne, Vanderbilt University Medical Center, Nashville, TN, USA.
Jean-Yves Cahn, Department of Hematology, CHU Grenoble Alpes, Université Grenoble Alpes, Grenoble, France.
Mitchell Cairo, Division of Pediatric Hematology, Oncology and Stem Cell Transplantation, Department of Pediatrics, New York Medical College, Valhalla, NY, USA.Follow
Paul Castillo, UF Health Shands Children's Hospital, Gainesville, FL, USA.
Edward Copelan, Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA.
Zachariah DeFilipp, Hematopoietic Cell Transplant and Cellular Therapy Program, Massachusetts General Hospital, Boston, MA, USA.
Miguel Angel Perez, Department of Hematology/Oncology, Hospital Infantil Universitario Niño Jesus, Madrid, Spain.
Mahmoud Elsawy, Division of Hematology, Department of Medicine, Dalhousie University, Halifax, NS, Canada.
Robert Peter Gale, Haematology Research Centre, Department of Immunology and Inflammation, Imperial College London, London, UK.
Biju George, Christian Medical College, Vellore, India.
Michael R. Grunwald, Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA.
Gerhard C. Hildebrandt, Markey Cancer Center, University of Kentucky, Lexington, KY, USA.
William J. Hogan, Division of Hematology/BMT, Mayo Clinic, Rochester, MN, USA.
Christopher G. Kanakry, Experimental Transplantation and Immunotherapy Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Ankit Kansagra

Author Type(s)

Faculty

DOI

10.1038/s41409-022-01625-6

Journal Title

Bone Marrow Transplantation

First Page

852

Document Type

Article

Publication Date

5-1-2022

Department

Pediatrics

Recommended Citation

Jimenez Jimenez, A. M., De Lima, M., Komanduri, K. V., Wang, T. P., Zhang, M., Chen, K., Abdel-Azim, H., Abid, M. B., Aljurf, M., Alkhateeb, H., Assal, A., Bacher, U., Baron, F., Battiwalla, M., Beitinjaneh, A., Bejanyan, N., Bhatt, V. R., Byrne, M., Cahn, J., Cairo, M., Castillo, P., Copelan, E., DeFilipp, Z., Perez, M. A., Elsawy, M., Gale, R. P., George, B., Grunwald, M. R., Hildebrandt, G. C., Hogan, W. J., Kanakry, C. G., & Kansagra, A. (2022). Correction To: An Adapted European Leukemianet Genetic Risk Stratification for Acute Myeloid Leukemia Patients Undergoing Allogeneic Hematopoietic Cell Transplant. a CIBMTR Analysis. Bone Marrow Transplantation, 57 (5), 852. https://doi.org/10.1038/s41409-022-01625-6